Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Researchers should follow the FACE-Q User's Guide for accurate results.

A protein in plants needs to bind two lipids to help with root hair growth, and this process is similar across different plant species.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Hydroxytyrosol may help treat hair loss by reducing inflammation and oxidative stress.

New-onset fibromyalgia after COVID-19 is poorly understood and needs more research.

MIS-A is a severe complication after COVID-19, mostly in young black males, needing more research and awareness.

Sex-limited chromosomes can affect traits not related to reproduction.

Most patients with cicatricial alopecias face significant psychological and social challenges due to their hair loss.

DCPA is a chronic leg infection often related to Staphylococcus aureus, affecting mostly young men in India.

DCPA is a chronic skin condition affecting the lower limbs, mainly in men, with unclear causes and treatments that often don't work well.

PrrH sRNA controls pyochelin gene expression in Pseudomonas aeruginosa based on heme levels.

Women with PCOS often face anxiety, depression, and low body appreciation, especially if they have alopecia, obesity, or a history of mental health issues.

Hair analysis has potential but is currently limited for monitoring medication adherence.

Lateral oblique forehead lines are caused by muscle movement, not sleep positions, and can be treated with botulinum toxin A.

Robotics in facial injections offers precision but is costly and lacks personal touch.

PRP therapy may improve skin and hair conditions, but more research with standard methods is needed.

Specific techniques can make facelift results look more natural.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

European guidelines recommend regular eye and ear exams, skin care, vitamin D supplements, and cautious use of medications for managing congenital ichthyoses.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Some drugs used to treat inflammation may cause hair loss.

Consider benefits and risks of new alopecia treatments for safety.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.

Reconstructing lower face gunshot injuries with a fibula and scalp flap is effective and gives good long-term results.

Leflunomide can cause severe hair loss in some rheumatoid arthritis patients.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Using calvarial bone for maxilla augmentation is less painful and allows for single-procedure dental implants.